Atomera (ATOM) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
20 Aug, 2026Executive summary
Achieved technical breakthroughs in GaN-on-Silicon for RF, surpassing industry benchmarks and enabling new RF device classes, which generated significant customer interest.
Advanced customer engagements in all target markets, with key milestones cleared in GAA transistor technology and growing validation from DRAM and NAND suppliers, especially for AI-driven applications.
Re-established and expanded value propositions for DRAM 4F² and NAND memory, validated by major suppliers and TCAD studies.
Focused on developing and licensing MST technology to improve performance and efficiency in integrated circuits, with ongoing R&D and patent expansion.
Financial highlights
Q2 2026 revenue was $158,000, primarily from wafer deliveries and engineering services, up from $132,000 in Q2 2025.
GAAP net loss for Q2 2026 was $6.3 million ($0.17/share), compared to $5.0 million ($0.17/share) in Q2 2025.
Non-GAAP/adjusted EBITDA loss was $5.0 million, versus $4.0 million in Q2 2025.
Operating expenses rose to $6.9 million from $5.2 million year-over-year, mainly due to higher R&D and G&A costs.
Cash, equivalents, and short-term investments totaled $38.4 million as of June 30, 2026, nearly doubling since year-end 2025.
Outlook and guidance
Annual non-GAAP operating expense for 2026 expected at the high end of $18.25–$18.75 million.
Management believes available capital is sufficient to fund operations for at least the next 12 months.
Focus remains on expanding MST technology adoption across logic, memory, RF-SOI, GaN, and power segments, with continued customer engagement and no guidance for 2027.
Latest events from Atomera
- MST advanced through customer evaluation, but commercial adoption and revenue remained unproven.ATOM
Q4 2016 - MST evaluations expanded, but commercialization remained unproven amid losses and cash burn.ATOM
Q4 2017 - Initial licenses marked progress, but commercialization remains gated by qualification and cash burn.ATOM
Q4 2018 - Revenue grew, but losses and commercialization hurdles remained substantial.ATOM
Q4 2019 - Cash rose to $37.9 million as a paid manufacturing JDA advanced MST toward commercialization.ATOM
Q4 2020 - JDA milestones and foundry evaluation expanded prospects, but commercialization remained unproven amid $15.7M losses.ATOM
Q4 2021 - Customer milestones advanced, but commercial royalties remain unproven amid continued losses.ATOM
Q4 2022 - FY 2023 revenue was $550K as MST reached two customer fabs and advanced toward royalties.ATOM
Q4 2023 - Q3 revenue was $0 as GAA, memory and IQE-led GaN programs advanced.ATOM
Q3 2026